Literature DB >> 31798211

Ethanol Ablation of Neck Metastases from Differentiated Thyroid Carcinoma.

Ricardo Paz-Fumagalli1, Xi Li1,2, Robert C Smallridge3.   

Abstract

Differentiated thyroid cancer often metastasizes to cervical lymph nodes, characteristically with slow growth rate and low-level aggressiveness. Cervical lymph node resection is the treatment of choice, but ethanol ablation offers a therapeutic option for patients with few nodes unresponsive to radioiodine therapy and who are poor surgical candidates. The ethanol ablation procedure is minimally invasive, guided sonographically, easily and safely repeated, and easily implemented with minimal technology and cost. Transient nerve injury is infrequent and virtually the only important complication. Current experience indicates that ethanol ablation has the safest therapeutic profile compared to surgery and thermal ablation, and the effectiveness is comparable to thermal ablation and approaches that of surgery. Well-designed clinical trials are lacking. © Thieme Medical Publishers.

Entities:  

Keywords:  ethanol; lymph node metastasis; nerve injury; thyroid carcinoma; ultrasound

Year:  2019        PMID: 31798211      PMCID: PMC6887524          DOI: 10.1055/s-0039-1696651

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  17 in total

1.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

2.  Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy.

Authors:  Ian D Hay; Robert A Lee; Caroline Davidge-Pitts; Carl C Reading; J William Charboneau
Journal:  Surgery       Date:  2013-10-28       Impact factor: 3.982

Review 3.  Percutaneous ethanol injection vs reoperation for locally recurrent papillary thyroid cancer: a systematic review and pooled analysis.

Authors:  Tatyana E Fontenot; Ahmad Deniwar; Parisha Bhatia; Zaid Al-Qurayshi; Gregory W Randolph; Emad Kandil
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-06       Impact factor: 6.223

4.  Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism.

Authors:  L Solbiati; A Giangrande; L De Pra; E Bellotti; P Cantù; C Ravetto
Journal:  Radiology       Date:  1985-06       Impact factor: 11.105

Review 5.  Efficacy and Safety of Radiofrequency and Ethanol Ablation for Treating Locally Recurrent Thyroid Cancer: A Systematic Review and Meta-Analysis.

Authors:  Chong Hyun Suh; Jung Hwan Baek; Young Jun Choi; Jeong Hyun Lee
Journal:  Thyroid       Date:  2016-02-10       Impact factor: 6.568

6.  Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.

Authors:  D Viola; G Materazzi; L Valerio; E Molinaro; L Agate; P Faviana; V Seccia; E Sensi; C Romei; P Piaggi; L Torregrossa; S Sellari-Franceschini; F Basolo; P Vitti; R Elisei; P Miccoli
Journal:  J Clin Endocrinol Metab       Date:  2015-01-15       Impact factor: 5.958

7.  Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.

Authors:  John M Stulak; Clive S Grant; David R Farley; Geoffrey B Thompson; Jon A van Heerden; Ian D Hay; Carl C Reading; J William Charboneau
Journal:  Arch Surg       Date:  2006-05

8.  Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma.

Authors:  B D Lewis; I D Hay; J W Charboneau; B McIver; C C Reading; J R Goellner
Journal:  AJR Am J Roentgenol       Date:  2002-03       Impact factor: 3.959

9.  Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma.

Authors:  Sameer William Qubain; Shizuo Nakano; Masamichi Baba; Sonshin Takao; Takashi Aikou
Journal:  Surgery       Date:  2002-03       Impact factor: 3.982

10.  Lymph node ratio predicts recurrence in papillary thyroid cancer.

Authors:  David F Schneider; Haggi Mazeh; Herbert Chen; Rebecca S Sippel
Journal:  Oncologist       Date:  2013-01-23
View more
  3 in total

1.  Long-Term Results of Treating With Ethanol Ablation 15 Adult Patients With cT1aN0 Papillary Thyroid Microcarcinoma.

Authors:  Ian D Hay; Robert A Lee; Suneetha Kaggal; John C Morris; Marius N Stan; M Regina Castro; Vahab Fatourechi; Geoffrey B Thompson; J William Charboneau; Carl C Reading
Journal:  J Endocr Soc       Date:  2020-09-15

2.  Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma.

Authors:  Pål Stefan Frich; Eva Sigstad; Audun Elnæs Berstad; Kristin Holgersen Fagerlid; Trond Harder Paulsen; Trine Bjøro; Liv Ingrid Flinder
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

3.  Prevalence and characteristics of vagus nerve variations on neck ultrasonography.

Authors:  Dongbin Ahn; Gil Joon Lee; Jin Ho Sohn; Jeong Kyu Kim
Journal:  Ultrasonography       Date:  2021-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.